Hepatocyte Paraffin 1 Antibody Does Not Distinguish Primary Ovarian Tumors with Hepatoid Differentiation from Metastatic Hepatocellular Carcinoma

International Journal of Gynecological Pathology

Volumn 23, Issue 1, 2004, Pages 58-64

  Pitman, Martha B ^a   Triratanachat, Surang ^a   Young, Robert H ^a   Oliva, Esther ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anti hepatocyte antibody; HepPar1; HP1; Immunohistochemistry; Metastatic hepatocellular carcinoma; Ovarian hepatoid carcinoma; Ovarian hepatoid yolk sac tumor

Indexed keywords

ALPHA FETOPROTEIN; HEPATOCYTE PARAFFIN 1 MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HEPATOID DIFFERENTIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL; LIVER CELL CARCINOMA; OVARIAN HEPATOID CARCINOMA; OVARY CARCINOMA; OVARY METASTASIS; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TUMOR CELL; TUMOR DIFFERENTIATION; YOLK SAC TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; ANTIBODIES, MONOCLONAL; CARCINOMA, HEPATOCELLULAR; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; OVARIAN NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0348141865     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Wennerberg AE, Nalesnik MA, Coleman WB. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol 1993;143:1050-4.
2. Minervini MI, Demetris AJ, Lee RG, et al. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 1997;10:686-92.
3. Wu PC, Fang JW, Lau VKT, et al. Classification of hepatocellular carcinoma according to hepatocetlular and biliary differentiation markers. Clinical and biological implications. Am J Path 1996;149:1167-75.
4. Kumagai I, Masuda T, Sato S, et al. Immunoreactivity to monoclonal antibody, Hep Par 1, in human hepatocellular carcinomas according to histopathological grade and histological pattern. Hepatol Res 2001;20:312-9.
5. Leong AS, Sormunen RT, Tsui WM, et al. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology 1998;33:318-24.
6. Muir T, Kakar S, Murphy LM, et al. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatic and extrahepatic tumors. Mod Pathol 2002;15:290A.
7. Chu PG, Ishizawa S, Wu E, et al. Hepatocyte antigen as a marker of hepatocellular carcinoma. An immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol 2002;26:978-88.
8. Fan Z, van de Rijn M, Montgomery K, et al. Hep Par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol 2003;16:137-44.
9. Zimmerman RL, Burke MA, Young NA, et al. Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver. Cancer 2001;93:288-91.
10. Wieczorek T, Pinkus J, Glickman J, et al. Comparison of thyroid transcription factor 1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma. Am J Clin Pathol 2002;118:911-21.
11. Siddiqui MT, Saboorian MH, Ashfaq R. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples. Cancer 2002;96:49-52.
12. Prat J, Bhan AK, Dickersin GR, et al. Hepatoid yolk sac tumor of the ovary (endodermal sinus tumor with hepatoid differentiation). A light microscopic, ultrastructural and immunohistochemical study of seven cases. Cancer 1982;50:2355-68.
13. Ishikura H, Scully RE. Hepatoid carcinoma of the ovary. A newly described tumor. Cancer 1987;60:2775-84.
14. Matsuura M, Ishikura H, Murakami K, et al. Hepatoid carcinoma of the ovary: A case report. Int J Gynecol Pathol 1991;10:302-10.
15. Young RH, Gersell DJ, Clement PB, et al. Hepatocellular carcinoma metastatic to the ovary: A report of three cases discovered during life with discussion of the differential diagnosis of hepatoid tumors of the ovary. Hum Pathol 1992;23:574-80.
16. Maitra A, Murakata LA, Albores-Saavedra J. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract. Am J Clin Pathol 2001;115:689-94.
17. Villari D, Caruso R, Grosso M, et al. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study. Pathology 2002;34:423-6.
18. Fasano M, Theise ND, Nalesnik M, et al. Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen. Mod Pathol 1998;11:934-8.
19. Tochigi N, Kishimoto T, Spuriatna Y, et al. Hepatoid carcinoma of the ovary: A report of three cases admixed with a common surface epithelial carcinoma. In J Gynecol Pathol 2003;22:266-71.
20. Murakata LA, Ishak KG, Nzeako UC. Clear cell carcinoma of the liver: a comparative immunohistochemical study with renal clear cell carcinoma. Mod Pathol 2000;13:874-81.
21. Kakar S, Muir T, Murphy LM, et al. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma. Am J Clin Pathol 2003;119:361-6.
22. MacSween RM, Burt A, Portmann B, et al. Pathology of the Liver. 4th ed. London: Churchill Livingstone; 2002.